Area of research
Psychiatry and Mental health · Social Psychology
Research interest
Research focused on Placebo and Kava, with related work in Clozapine, Clinical Global Impression, Anxiety. Notable publications include 'An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels', 'Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and...', and 'Kava in the Treatment of Generalized Anxiety Disorder'.
The Brain Economy: Advancing Brain Science to Better Understand the Modern Economy
Global prevalence of mild cognitive impairment among older adults living in nursing homes: a meta-analysis and systematic review of epidemiological surveys
Accelerated intermittent theta burst stimulation for major depressive disorder or bipolar depression: A systematic review and meta-analysis
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
Assessing dietary, exercise, and non-pharmacological modalities within psychiatric hospitals
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
A Brain Capital Grand Strategy: toward economic reimagination
Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials
Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trials
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
Do Asian Patients Require Only Half of the Clozapine Dose Prescribed for Caucasians? A Critical Overview
Prescription of antipsychotic and concomitant medications for adult Asian schizophrenia patients: Findings of the 2016 Research on Asian Psychotropic Prescription Patterns (REAP) survey
Adjunctive Metformin for Antipsychotic-Induced Dyslipidemia: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
<i>N</i>‐acetylcysteine for major mental disorders: a systematic review and meta‐analysis of randomized controlled trials
Prevalence of major depressive disorder in older adults in China: A systematic review and meta-analysis
Neurocognitive dysfunction in subjects at clinical high risk for psychosis: A meta-analysis
Combination of Metformin and Lifestyle Intervention for Antipsychotic-Related Weight Gain: A Meta-Analysis of Randomized Controlled Trials
Adjunctive raloxifene for postmenopausal women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials
Short-term efficacy and tolerability of lurasidone in the treatment of acute schizophrenia: A meta-analysis of randomized controlled trials
Meta-analysis of the Efficacy and Safety of Adjunctive Rosuvastatin for Dyslipidemia in Patients with Schizophrenia.
Corrigendum to “Short-term efficacy and tolerability of lurasidone in the treatment of acute schizophrenia: A meta-analysis of randomized controlled trials” [J. Psychiatr. Res. 103 (2018) 244-251]
Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial
Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials
Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials
Adjunctive metformin for antipsychotic-related hyperprolactinemia: A meta-analysis of randomized controlled trials
Erythropoietin for Cognitive Deficits Associated with Schizophrenia, Bipolar Disorder, and Major Depression: A Systematic Review
Comparison of the 32‐item Hypomania Checklist, the 33‐item Hypomania Checklist, and the Mood Disorders Questionnaire for bipolar disorder
Adjunctive azapirone for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials
Adjunctive Melatonin for Tardive Dyskinesia in Patients with Schizophrenia: A Meta-Analysis.